francis-crick-institute-17-c-wellcome-images
Photo courtesy of the Francis Crick Institute - (c)Wellcome Images
11 October 2016Big Pharma

Francis Crick Institute: a new centre of excellence

“Intellectual property will help to move projects at the Francis Crick Institute forward. It will be something that supports that process rather than something that gets in the way,” says Stephanie Pilkington, partner at Potter Clarkson, about the role IP will play in translating research at the institute into tangible benefits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
11 February 2026   Courts on both sides of the Atlantic recorded a flurry of settlements this week, as Astellas, GSK, and Alexion drew a line under long-running disputes with generic rivals.
Big Pharma
27 November 2025   Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.
Big Pharma
20 November 2025   A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance.